April 22, 2024

TREFFpunkt Gesundheitsindustrie: Mensch. Maschine. Miteinander? KI & Robotik in der Medizin

TREFFpunkt Gesundheitsindustrie: Mensch. Maschine. Miteinander? KI & Robotik in der Medizin
Go back

TREFFpunkt Gesundheitsindustrie 2026 | Mensch. Maschine. Miteinander? KI & Robotik in der Medizin

Automatisierung, Robotik und Künstliche Intelligenz (KI) sind Motoren fürInnovation, Effizienz und Versorgungssicherheit im Gesundheitswesen. Ob akuter Fachkräftemangel, demographischer Wandel oder steigender Kostendruck – als Schlüsseltechnologien haben sie das Potenzial, zentrale Herausforderungen unserer Zeit zu bewältigen. Durch optimiertes Datenmanagement, effiziente Ressourcenplanung, KI-gestützte Diagnostik und Therapie, Robotik sowie smarte Assistenten versprechen Automatisierung und KI wirkungsvolle Lösungen und Entlastung.

Der TREFFpunkt Gesundheitsindustrie bringt Entscheider, Vordenkerinnen und Innovatoren aus Unternehmen und Start-ups, Forschung und Versorgung zusammen, um Automatisierung, Robotik und KI zu beleuchten, disruptive Technologien live zu erleben und gemeinsam Lösungen für die Zukunft der Branch ezu diskutieren.

Wann: 19. März 2026
Wo: Hospitalhof Stuttgart

Hier geht’s zum Programm: www.treffpunkt-gesundheitsindustrie.de/programm
Jetzt kostenfrei anmelden unter www.treffpunkt-gesundheitsindustrie.de/anmeldung!

Organisiert wird das Event von der Landesagentur BIOPRO Baden-Württemberg GmbH. Gemeinsam mit dem Regionalpartner 2026, der BioRegio STERN Management GmbH, macht sie Innovationen aus THE LÄND sichtbar.

register now

Our latest News

discover more
Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Professor Dr. Hanns-Peter Knaebel has been appointed Director of Medicine at the Heidelberg and Mannheim University Hospitals Network

Effective June 1, 2026, the Supervisory Board has appointed Hanns-Peter Knaebel, Chairman of the Executive Board, to serve as Chief Medical Officer. This move will ensure that the dynamic phase of medical strategy development and transformation within the group is overseen and managed centrally by the full Executive Board. Full Text in German below. Professor […]

read more
ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

ProtaGene Announces Strategic Partnership with the Life Science business of Merck to Expand Comprehensive Biologics Testing Solutions

HEILBRONN, Germany, May 14, 2026 – ProtaGene today announced a strategic partnership with the Life Science business of Merck, which operates as MilliporeSigma in the United States and Canada, to provide biopharmaceutical customers with an end-to-end testing solution across the entire biopharmaceutical product lifecycle, from early-stage development through GMP release testing. ProtaGene’s expertise in advanced protein […]

read more
Universität Heidelberg Successful with Application for Collaborative Research Centre

Universität Heidelberg Successful with Application for Collaborative Research Centre

DFG funds extended CRC with approximately 17.4 million euros Heidelberg University has been successful in the latest approval round of the German Research Foundation (DFG) with a grant application for a major research consortium: The Collaborative Research Centre “Molecular Circuits of Heart Disease” (CRC 1550), based at the Medical Faculty Heidelberg, is entering a second […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp